These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20576279)

  • 1. [Mitochondrial DNA depletion and POLG mutations in a patient with sensory ataxia, dysarthria and ophthalmoplegia].
    Posada IJ; Gallardo ME; Domínguez C; Rivera H; Cabello A; Arenas J; Martín MA; Garesse R; Bornstein B
    Med Clin (Barc); 2010 Oct; 135(10):452-5. PubMed ID: 20576279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations.
    Milone M; Brunetti-Pierri N; Tang LY; Kumar N; Mezei MM; Josephs K; Powell S; Simpson E; Wong LJ
    Neuromuscul Disord; 2008 Aug; 18(8):626-32. PubMed ID: 18585914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations.
    Weiss MD; Saneto RP
    Muscle Nerve; 2010 Jun; 41(6):882-5. PubMed ID: 20513108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions.
    Hanisch F; Kornhuber M; Alston CL; Taylor RW; Deschauer M; Zierz S
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):630-4. PubMed ID: 25143630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation.
    McHugh JC; Lonergan R; Howley R; O'Rourke K; Taylor RW; Farrell M; Hutchinson M; Connolly S
    Muscle Nerve; 2010 Feb; 41(2):265-9. PubMed ID: 19813183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset ataxia with progressive external ophthalmoplegia associated with POLG mutation: autosomal recessive mitochondrial ataxic syndrome or SANDO?
    Habek M; Barun B; Adamec I; Mitrović Z; Ozretić D; Brinar VV
    Neurologist; 2012 Sep; 18(5):287-9. PubMed ID: 22931735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia.
    Van Goethem G; Martin JJ; Dermaut B; Löfgren A; Wibail A; Ververken D; Tack P; Dehaene I; Van Zandijcke M; Moonen M; Ceuterick C; De Jonghe P; Van Broeckhoven C
    Neuromuscul Disord; 2003 Feb; 13(2):133-42. PubMed ID: 12565911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in spacer region of POLG associated with ataxia neuropathy spectrum and gastroparesis.
    Bostan A; Glibert G; Dachy B; Dan B
    Auton Neurosci; 2012 Sep; 170(1-2):70-2. PubMed ID: 22805437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement.
    Van Goethem G; Luoma P; Rantamäki M; Al Memar A; Kaakkola S; Hackman P; Krahe R; Löfgren A; Martin JJ; De Jonghe P; Suomalainen A; Udd B; Van Broeckhoven C
    Neurology; 2004 Oct; 63(7):1251-7. PubMed ID: 15477547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis with multiple mitochondrial DNA deletions].
    Tanaka K; Tateishi T; Kawamura N; Ohyagi Y; Urata M; Kira J
    Rinsho Shinkeigaku; 2013; 53(3):205-11. PubMed ID: 23524600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
    Luoma P; Melberg A; Rinne JO; Kaukonen JA; Nupponen NN; Chalmers RM; Oldfors A; Rautakorpi I; Peltonen L; Majamaa K; Somer H; Suomalainen A
    Lancet; 2004 Sep 4-10; 364(9437):875-82. PubMed ID: 15351195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Molecular Features of POLG-Related Sensory Ataxic Neuropathy with Dysarthria and Ophthalmoparesis.
    Li LX; Jiang LT; Pan YG; Zhang XL; Pan LZ; Nie ZY; Chen YH; Jin LJ
    J Mol Neurosci; 2021 Dec; 71(12):2462-2467. PubMed ID: 33791913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI findings in SANDO variety of the ataxia-neuropathy spectrum with a novel mutation in POLG (c.3287G>T): A case report.
    Parada-Garza JD; López-Valencia G; Miranda-García LA; Pérez-García G; Ruiz-Sandoval JL
    Neuromuscul Disord; 2020 Jul; 30(7):590-592. PubMed ID: 32600829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
    González-Vioque E; Blázquez A; Fernández-Moreira D; Bornstein B; Bautista J; Arpa J; Navarro C; Campos Y; Fernández-Moreno MA; Garesse R; Arenas J; Martín MA
    Arch Neurol; 2006 Jan; 63(1):107-11. PubMed ID: 16401742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.
    Rajakulendran S; Pitceathly RD; Taanman JW; Costello H; Sweeney MG; Woodward CE; Jaunmuktane Z; Holton JL; Jacques TS; Harding BN; Fratter C; Hanna MG; Rahman S
    PLoS One; 2016; 11(1):e0145500. PubMed ID: 26735972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease.
    Fadic R; Russell JA; Vedanarayanan VV; Lehar M; Kuncl RW; Johns DR
    Neurology; 1997 Jul; 49(1):239-45. PubMed ID: 9222196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
    Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
    Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations.
    Tzoulis C; Papingji M; Fiskestrand T; Røste LS; Bindoff LA
    Acta Neurol Scand Suppl; 2009; (189):38-41. PubMed ID: 19566497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.
    Pitayu L; Baruffini E; Rodier C; Rötig A; Lodi T; Delahodde A
    Hum Mol Genet; 2016 Feb; 25(4):715-27. PubMed ID: 26692522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unfolding clinical spectrum of POLG mutations.
    Blok MJ; van den Bosch BJ; Jongen E; Hendrickx A; de Die-Smulders CE; Hoogendijk JE; Brusse E; de Visser M; Poll-The BT; Bierau J; de Coo IF; Smeets HJ
    J Med Genet; 2009 Nov; 46(11):776-85. PubMed ID: 19578034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.